Invitrogen Introduces Omnia™ Kinase Assays
Product News May 29, 2006
Invitrogen Corporation has announced the launch of its Omnia™ Kinase Assays for the rapid, homogenous and sensitive detection of enzymatic activity under physiological ATP concentrations.
Scientists can mix reagents, read real-time fluorescent signals and get results in under an hour.
Omnia™ is designed to offer a simple mix and read procedure, streamlining assay set-up and speeding data collection.